These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26270429)

  • 21. Stimulant medication use in college students: comparison of appropriate users, misusers, and nonusers.
    Hartung CM; Canu WH; Cleveland CS; Lefler EK; Mignogna MJ; Fedele DA; Correia CJ; Leffingwell TR; Clapp JD
    Psychol Addict Behav; 2013 Sep; 27(3):832-40. PubMed ID: 24059834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adults with ADHD: use and misuse of stimulant medication as reported by patients and their primary care physicians.
    Lensing MB; Zeiner P; Sandvik L; Opjordsmoen S
    Atten Defic Hyperact Disord; 2013 Dec; 5(4):369-76. PubMed ID: 23975605
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attention-deficit/hyperactivity disorder and substance abuse.
    Harstad E; Levy S;
    Pediatrics; 2014 Jul; 134(1):e293-301. PubMed ID: 24982106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Changing Drug Culture: Use and Misuse of Cognition-Enhancing Drugs.
    Albertson TE; Chenoweth JA; Colby DK; Sutter ME
    FP Essent; 2016 Feb; 441():25-9. PubMed ID: 26881770
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attention Deficit Hyperactivity Disorder in Athletes.
    Ciocca M
    Clin Sports Med; 2019 Oct; 38(4):545-554. PubMed ID: 31472765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adderall in the land of Oz.
    Hammerschlag C
    Caring; 2013; 32(2):55. PubMed ID: 23697076
    [No Abstract]   [Full Text] [Related]  

  • 28. Risks and benefits of available treatments for adult ADHD.
    Newcorn JH
    J Clin Psychiatry; 2011 Mar; 72(3):e12. PubMed ID: 21450148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspectives of US Adolescents on Diverted Stimulant Use.
    Hadler N; Strome A; Waselewski M; Herbert K; Harper C; Chang T
    J Pediatr; 2021 Aug; 235():190-195. PubMed ID: 33862023
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Does quality of life outweigh the cardiovascular risks of stimulant medication in a child with ADHD and hypertrophic cardiomyopathy?
    Senderey E; Sousa J; Stavitsky M
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the efficacy of medications for adult attention-deficit/hyperactivity disorder using meta-analysis of effect sizes.
    Faraone SV; Glatt SJ
    J Clin Psychiatry; 2010 Jun; 71(6):754-63. PubMed ID: 20051220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attention-Deficit Hyperactivity Disorder: Clinical Considerations for Women.
    Marraccini ME; Weyandt LL; Gudmundsdottir BG; Oster DR; McCallum A
    J Midwifery Womens Health; 2017 Nov; 62(6):684-695. PubMed ID: 29160614
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative analysis of antidepressants and stimulants for the treatment of adults with attention-deficit hyperactivity disorder.
    Higgins ES
    J Fam Pract; 1999 Jan; 48(1):15-20. PubMed ID: 9934377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First-onset tics in patients with attention-deficit-hyperactivity disorder: impact of stimulants.
    Roessner V; Robatzek M; Knapp G; Banaschewski T; Rothenberger A
    Dev Med Child Neurol; 2006 Jul; 48(7):616-21. PubMed ID: 16780635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Do conduct problems and sensation seeking moderate the association between ADHD and three types of stimulant use in a college population?
    Van Eck K; Markle RS; Flory K
    Psychol Addict Behav; 2012 Dec; 26(4):939-47. PubMed ID: 22428861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacotherapy of pediatric attention-deficit/hyperactivity disorder.
    Vaughan B; Kratochvil CJ
    Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):941-55. PubMed ID: 23040908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The efficacy and safety profile of lisdexamfetamine dimesylate, a prodrug of d-amphetamine, for the treatment of attention-deficit/hyperactivity disorder in children and adults.
    Najib J
    Clin Ther; 2009 Jan; 31(1):142-76. PubMed ID: 19243715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adherence to stimulants in adult ADHD.
    O'Callaghan P
    Atten Defic Hyperact Disord; 2014 Jun; 6(2):111-20. PubMed ID: 24604104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Does stimulant treatment lead to substance use disorders?
    Faraone SV; Wilens T
    J Clin Psychiatry; 2003; 64 Suppl 11():9-13. PubMed ID: 14529324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ADHD medication use, adherence, persistence and cost among Texas Medicaid children.
    Barner JC; Khoza S; Oladapo A
    Curr Med Res Opin; 2011; 27 Suppl 2():13-22. PubMed ID: 21973228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.